02420nam a2200325 a 4500001001200000003000800012006001900020007001500039008004100054010001700095020002500112020002700137040002100164035002100185050002600206082002000232100002300252245013400275260003500409300002800444504005100472505051000523520067201033533015201705650004801857655002901905710001701934856012601951999001702077ebr10641813CaPaEBRm     o  u        cr cn|||||||||121010s2013    njuad   sb    001 0 eng d  z  2012032915  z9781118487471 (pbk.)  z9781118511299 (e-book)  aCaPaEBRcCaPaEBR  a(OCoLC)83146403214aHD9665.5b.L36 2013eb04a338.4/761512231 aLaMattina, John L.10aDevalued and distrustedh[electronic resource] :bcan the pharmaceutical industry restore its broken image? /cJohn L. LaMattina.  aHoboken, N.J. :bWiley,c2013.  aix, 125 p. :bcol. ill.  aIncludes bibliographical references and index.8 aMachine generated contents note:  Introduction Part 1. "The 4 Secrets That Drug Companies Don't Want You to Know" Part 2. What Has Happened to R&D Productivity? a. Impact of Mergers b. Impact of FDA c. Impact of Payers Part 3. Challenges in Key Therapeutic Areas for Improving Health a. Cancer b. Diseases of the Brain c. Cardiovascular Disease d. Diabetes e. Bacterial Infections Part 4. Improving R&D Output a. View of Others b. Personal Vision Part 5. Restoring the Pharma Image Part 6. Final Thoughts.  a"While the pharmaceutical industry can play an important role in converting the knowledge generated by the Human Genome Project into new medicines, it also faces a popular perception that it is simply out to make money by promoting unsafe medicines to an unsuspecting public. Written by former Pfizer president John LaMattina, this book addresses the progress that the industry has made in improving its abilities to measure both the risk and benefits of its new medicines, where the industry should invest its R&D resources, and how the industry can rehabilitate its image. Essential reading for pharmaceutical executives and professionals"--cProvided by publisher.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2015.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aPharmaceutical industryxCorrupt practices. 7aElectronic books.2local2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10641813zAn electronic book accessible through the World Wide Web; click to view  c31778d31778